NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
World Federation of Hemophilia: Eptacog Beta in Severe Bleeds – Insights From PERSEPT Trials
Guy Young/LinkedIn
Dec 13, 2025, 08:59

World Federation of Hemophilia: Eptacog Beta in Severe Bleeds – Insights From PERSEPT Trials

World Federation of Hemophilia shared on LinkedIn:

”Severe bleeds in hemophilia with inhibitors remain a major challenge. Post hoc analysis of the PERSEPT 1 and 2 trials highlights how eptacog beta can offer effective treatment options when they’re needed most.”

Read the full article here.

Article: Treatment of severe bleeds with eptacog beta in hemophilia A or B with inhibitors: a post hoc analysis of the PERSEPT 1 and 2 trials

Authors: Guy Young, Johnny Mahlangu, Lisa N. Boggio, Manuel Carcao, Yesim Dargaud, Miguel Escobar, Adam Giermasz, Cédric Hermans, Philip Kuriakose, Wolfgang Miesbach, Danielle Nance, Amina Rafique, Robert F. Sidonio Jr., Kateryna V. Vilchevska, Michael Wang, Steven W. Pipe

World Federation of Hemophilia

Stay updated with Hemostasis Today.

Adam Giermasz Amina Rafique bleeding disorders Cedric Hermans Danielle Nance Eptacog Beta Guy Young Health Hemophilia Hemostasis Today inhibitors Johnny Mahlangu Kateryna V. Vilchevska Lisa N. Boggio Manuel Carcao Medicine Michael Wang Miguel Escobar Philip Kuriakose Robert F. Sidonio Jr. Steven W. Pipe WFH Wolfgang Miesbach World Federation of Hemophilia Yesim Dargaud
NewsFeed